Asthma Medication Formoterol Shows Promise for Treating Fatty Liver Disease

Asthma medication formoterol shows promise for treating fatty liver disease

MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide.

Common asthma drug shows promise for reversing fatty liver

MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide. It is also a leading cause of liver transplantation, yet treatment options remain limited.

The Asthma Drug That Accidentally Reversed Fatty Liver Disease in Mice

The livers were not supposed to be part of the experiment. Joshua Lipschutz and his team at the Medical University of South Carolina were studying something else entirely, running a mouse model of diabetic kidney disease, checking whether formoterol, a decades-old asthma drug, could slow the renal damage that so often grinds through patients with type 2 diabetes. The kidney results were encouraging. But when the researchers examined the surround…

Asthma Medication Exhibits Potential to Reverse Fatty Liver Disease

Scientists at the Medical University of South Carolina (MUSC) have unveiled a promising new avenue in the fight against metabolic dysfunction-associated steatohepatitis (MASH), a chronic liver condition affecting hundreds of millions globally and a leading indication for liver transplantation. Their groundbreaking findings suggest that formoterol, a medication historically prescribed for respiratory diseases such as asthma […]